Gerald M Blumenstock, Executive Vice President of Research, Development & Engineering at Axcelis Technologies Inc. (), sold shares of the company’s common stock totaling $177,284. The transaction took place on May 21, 2026.
Mr. Blumenstock disposed of 1,161 shares at a price of $152.70 per share.
Following this sale, Mr. Blumenstock directly holds 20,493 shares. These shares are issuable upon vesting of restricted stock units granted to the reporting person under the 2012 Equity Incentive Plan and are subject to forfeiture.
For deeper insights into ACLS’s valuation and performance, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Axcelis Technologies reported its first-quarter 2026 financial results, which fell short of expectations. The company announced earnings per share of $0.72, which was below the anticipated $1.01. Additionally, Axcelis reported revenue of $199 million, missing the forecasted $207.23 million. Despite these results, BofA Securities adjusted its price target for Axcelis Technologies, increasing it from $90 to $130, while maintaining an Underperform rating. The firm highlighted that first-quarter results and second-quarter guidance were generally in line with expectations. Axcelis’ fiscal 2026 sales outlook remains unchanged, projecting flat year-over-year growth. These developments reflect the company’s current financial performance and market outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.